Received May 19, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (HEPLISAV-B) | DYNAVAX TECHNOLOGIES CORPORATION | 1 | 947986 | IM / LA |
Site: Pain at Injection Site-Medium, Additional Details: PATIENT RECEIVED 3 VACCINES. VACCINES WERE ADMINISTERED PER STANDARD PROTOCOL USING APPROPRIATE ADMIN AVOIDING SIRVA. WITHIN SECONDS AFTER ADMIN, PT REPORTED PAIN AND BEGAN TO RAISE HER VOICE. PT WAS LAERT, RESPONSIVE AND ABLE TO CONVERSE NORMALLY. NOP VISIBLE ACUTE DISTRESS SIGNS OTHER THAN PAIN COMPLAINT WERE NOTED. PT WAS ADVISED THAT SORENESS/PAIN CAN OCCUR AFTER VACCINES, ADVISED TO USE TYLENOL AS APPROPRIATE FOR DISCOMFORT IF NOT CONTRAINDICATED, Other Vaccines: VaccineTypeBrand: gardasil 9; Manufacturer: merck; LotNumber: z012144; Route: IM; BodySite: RIGHT ARM; Dose: ; VaxDate: UNKNOWN, VaccineTypeBrand: PREVNAR 20; Manufacturer: PFIZER; LotNumber: MN0749; Route: IM; BodySite: LEFT ARM; Dose: ; VaxDate: UNKNOWN